MedTrace Logo

Pain Reduction After Cholecystectomy

NCT01199406 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2010-09-13

No results posted yet for this study

Summary

To determine the effect of combined intracutaneous infiltration and intraperitoneal instillation of 80 mL 0,125% levobupivacaine prior to the start of laparoscopic cholecystectomy on abdominal pain up to 24 hours after surgery.

Conditions

  • Cholecystolithiasis
  • Postoperative Pain

Interventions

DRUG

Levobupivacaine

0.125% levobupivacaine 80 mL (100 mg) intraoperative, 20 mL subcutaneously and 60 mL intraperitoneally

Sponsors & Collaborators

  • Meander Medical Center

    lead OTHER

Principal Investigators

  • Werner A Draaisma, MD, PhD · Meander MC

  • Bart Hilvering, MD · Meander MC

  • Esther CJ Consten, MD, PhD · Meander MC

  • Kristine E Kofman, MD · Meander MC

  • Rene M Valk, MD · Meander MC

  • Jarmila DW Van der Bilt, MD · Meander MC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199406 on ClinicalTrials.gov